Media analysis
Media · post-earnings takeaway
The Payer Record · ALHC · Q2 2026
Alignment Healthcare Q2 2026 — the filed record
Why the Results ChangedExact source language · this is not analyst valuation logic
Media analysis
Media · post-earnings takeaway
“The third quarter is expected to bring a seasonally higher ratio because of greater new-member acuity, a flatter Part D cost slope and added clinical investment.”
Media analysis
Media · post-earnings takeaway
“The company now expects 2026 revenues of $5.195 billion-$5.225 billion and membership of 298,000-301,000.”
Management
Management · earnings release
John Kao · earnings statement
“Our second quarter results underscore the strength of our purpose-built Medicare Advantage platform and place us in a strong position to deliver upon our full-year objectives,”
Target Changes — Why Not AvailableAction is public · model logic is not
Analyst action
Reported action · explanation unavailable
Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns
Why the target changed: not public. The linked report does not provide the analyst’s revised forecasts, valuation multiple, or assumptions. The results and guidance above may have informed the action, but the public record does not establish that connection.
Analyst action
Reported action · explanation unavailable
J.P. Morgan Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Cuts Target Price to $22
Why the target changed: not public. The linked report does not provide the analyst’s revised forecasts, valuation multiple, or assumptions. The results and guidance above may have informed the action, but the public record does not establish that connection.
Sourced Takeaways5 takeaways · every bullet sourced
- Revenue was $1,335.6M; +31.6% YoY.Filed8-K 2026-07-30 · EX-99.1
- Benefit expense ratio was 86.3%; -40bp YoY.Filed8-K 2026-07-30 · EX-99.1
- Net income was $36.6M; versus $15.7M a year earlier.Filed8-K 2026-07-30 · EX-99.1
- Adjusted EBITDA was $68.1M; +48.4% YoY; FY guide $145M–$163M.Filed8-K 2026-07-30 · EX-99.1
- Diluted EPS (GAAP) was $0.17; versus $0.07 a year earlier.Filed8-K 2026-07-30 · EX-99.1
The NumbersReported · published precision · every figure sourced
| Metric | Q2 2026 | Prior yr | YoY | FY Guide |
|---|---|---|---|---|
| Revenue | $1,335.6M | — | +31.6% | — |
| Benefit expense ratio | 86.3% | — | -40bp | — |
| Net income | $36.6M | $15.7M | — | — |
| Adjusted EBITDA | $68.1M | — | +48.4% | $145M–$163M |
| Diluted EPS (GAAP) | $0.17 | $0.07 | — | — |
CMS ROWS ARE GROUND TRUTH, INDEPENDENT OF COMPANY REPORTING · PRECISION PER BRAND SPEC
The DocumentsEverything this record is built from
The filing every figure on this page is read from.
8-K 2026-07-30 · EX-99.1